National Drug Shortages: New Shortages by Year
January 2001 to March 31, 2021
National Drug Shortages: New Shortages by Year - Percent Injectable
January 2001 to March 31, 2021, % Injectable
National Drug Shortages: Active Shortages by Quarter
March 31, 2021
National Drug Shortages: Active Shortages Top 5 Drug Classes
National Drug Shortages: Common Drug Classes in Short Supply
New Shortages Reported: 2016–2021
National Drug Shortages
Reasons for Shortages as Determined by UUDIS During Investigation — 2020
What Do These Numbers Mean?
- The rate of new shortages has decreased, but a large number are still active and posing continued problems for patient care such as local anesthetics (bupivacaine, lidocaine, mepivacaine) and critical antidotes (succimer, physostigmine).
- New shortages may occur as manufacturing capacity is prioritized for vaccine production.
- During 2020, hospitals experienced significant shortages of analgesics, sedatives, and paralytics due to unprecedented demand created by large numbers of critically ill patients with COVID-19.
- Half of new shortages in 2020 were injectable products used in hospitals.
Actions to Improve Drug Shortages
AHA/AMA/ASHP/USP summit to examine national security implications of global manufacturing
The CARES Act includes provisions for shortages and readiness
National Academies of Science, Engineering, and Medicine to examine the security of America’s medical product supply chain (report 2022).